AeroVironment

AeroVironment is no longer a small-cap tactical-drone shop — the May 2025 close of the all-stock BlueHalo merger doubled the revenue base from USD 820 M to over USD 1.7 B run-rate and added directed-energy weapons, space-domain awareness and counter-UAS to a pure loitering-munition franchise. The combined entity sits at USD 2.1 B trailing revenue exiting Q1/2026, with a backlog of USD 880 M — the largest in company history.

The hero product is still Switchblade 300/600 — single-use loitering munition with the GPS-denied autonomy advantage Ukraine validated through 2023-2025. The US Army awarded a USD 990 M five-year Switchblade IDIQ in March 2026 (replacing an earlier USD 350 M ceiling), explicitly to support Pentagon's Replicator initiative — 10.000 attritable autonomous systems by August 2026.

The undertold story is the JUMP-20 medium-altitude UAS — the platform won the US Army's FTUAS program in 2024 over RQ-7 Shadow, ramping to USD 380 M/year by 2027. Plus the legacy small-UAS Raven/Puma family is on a steady DoD/foreign-military-sales rhythm of USD 220-260 M annually.

Institutional ownership is heavily passive — Vanguard 8.9%, BlackRock 7.4%, State Street 4.6% — but the active conviction names are revealing. Capital International became a 5%-holder in Q4/2025 (right before the BlueHalo close), and Cathie Wood's ARKX added AVAV to its top-15 names in February 2026 at an average USD 174 entry. No mega-name hedge fund has filed yet but Stanley Druckenmiller's Duquesne family office disclosed a 1.1% position in a side-letter as of Q1/2026.

Insider activity has been quiet — the BlueHalo all-stock consideration locked most former BlueHalo insiders into 12-month no-sale agreements that don't expire until May 2026. Pay attention to the May-June 2026 13F window — large open-market selling by ex-BlueHalo execs would be the negative signal.

Short interest is modest at 4.1% of float, mostly tied to convertible-note arbitrage from the 2024 USD 200 M raise. Not a contrarian-fund target.

Forward P/E of 39x on FY27 consensus EPS USD 4.05 is the headline pushback. But EV/Sales forward of 3.4x is in line with L3Harris (3.1x) and below Anduril private mark (rumored 8x). The bull math: if FY28 revenue lands at USD 2.9 B with 19% EBITDA margin, EV/EBITDA forward drops to 14x — defense-prime range. Analyst target USD 310 (+96% from current USD 158) is dramatic but reflects: (a) Replicator funding visibility, (b) BlueHalo synergy capture, (c) counter-UAS optionality. Jefferies USD 320, Baird USD 295, BofA USD 285. The street has not modeled meaningful FMS upside — bull math gets to USD 380 on a single Taiwan/Australia counter-UAS award.

1. June 2026 Q4 earnings: First full-quarter combined-entity print + FY27 guide; market needs to see BlueHalo integration on-track and Switchblade IDIQ utilization at >30%
2. August 2026 Replicator milestone: Pentagon Replicator initiative reports formal 10.000-unit-fielded checkpoint; AVAV is the only fielded loitering-munition vendor, contract visibility for 2027-2028 lands here
3. Q4 2026 FY27 budget request: Counter-UAS line item in Pentagon FY27 request — consensus is USD 1.5 B incremental; if it lands at USD 2 B+, AVAV BlueHalo Locust/Titan portfolio sees direct upside

AeroVironment is the cleanest publicly-listed Pentagon-tactical-edge play in 2026 — Anduril is still private, Shield AI is still private, and Skydio is consumer-tilted. The Replicator program created a US-government-funded TAM that did not exist 18 months ago, and AVAV is the only fielded vendor at scale. The risk is purely about execution: the BlueHalo merger has to deliver on integration timeline and the Salt Lake City production ramp has to hit Q1/2027 without quality issues. I would size this 1.5-2.5% of equity — it is too volatile (52w range USD 88-258) for a core position. Stop at USD 130 (below the 200-day moving average), with a planned add at USD 175 on a clean Q4 print. This is a multi-year story but expect 25% drawdowns along the way every time defense-budget headlines wobble.